Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

New and repurposed treatments are improving outcomes in dermatology.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Stem cell niches are crucial for maintaining stem cells, with Paneth cells and TGF-beta playing key roles.

The editorial introduces studies on various cosmetic and laser treatments, their effectiveness, and posttreatment care.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Self-assembling RADA16-I hydrogels with bioactive peptides significantly improve wound healing.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Plant sterols have health benefits like lowering cholesterol, but more research is needed to understand their effects and improve their extraction and sustainability.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

At-home laser and light skin devices are less effective than professional ones, with limited scientific evaluation, but some show promise for wrinkles, hair growth, and acne.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Apremilast did not work for treating severe alopecia areata.

A holistic approach, including medical treatments, lifestyle changes, and mental health support, is crucial for managing hirsutism in women.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.